Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
2.
J Natl Med Assoc ; 115(2): 144-146, 2023 Apr.
Article de Anglais | MEDLINE | ID: mdl-36681552

RÉSUMÉ

In this paper, we reported a 37-year-old man who developed several lymphadenopathies after using the second dose of Pfizer-BioNtech vaccination against SARS-CoV-2. The excisional lymph node biopsy showed eosinophil-rich inflammation with micro-abscesses. Although eosinophilic dermatosis and eosinophilic myocarditis have been described previously following COVID-19 vaccinations, eosinophilic lymph node abscess was not reported in the literature. In our case, all lesions were completely recovered with steroid treatment. The patient has been doing well and no recurrence has been observed for six months.


Sujet(s)
COVID-19 , Lymphadénopathie , Mâle , Humains , Adulte , Abcès/étiologie , Vaccins contre la COVID-19/effets indésirables , SARS-CoV-2 , Lymphadénopathie/étiologie , Noeuds lymphatiques
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE